Resources

A recent webinar hosted by members of the Mobilise-D consortium revealed that construct validity was supported for multiple digital mobility outcomes (DMOs). The clinical validation studies involved almost 2,400 patients and evaluated 24 DMOs across 4 participant cohorts: chronic obstructive pulmonary disease… Read More

Productivity in biopharmaceutical R&D is driven by a combination of effectiveness (doing the right things) and efficiency (doing things right). The framework below was recently presented by Roche at the recent Digital Biomarkers conference in Basel, and illustrates a number of levers… Read More

Walking is something most of us take for granted. That belies the fact that it is an incredibly complex activity, requiring dynamic interactions between multiple systems throughout the body. With all systems fully functional, the brain takes in visual information on your… Read More

Note: This is an abridged version our white paper on ‘How to Measure Mobility in the Real World’. To see the full paper with additional results, comprehensive references and more detail on the methodology, please download the paper on our website here. Measuring… Read More

Mobility loss is common, with about 1 billion people globally living with some form of mobility loss as a result of respiratory, cardiovascular, musculoskeletal, neurological or other issues. Its consequences are severe and go well beyond the physical. Loss of mobility can also have a… Read More

Note: This is the executive summary of our white paper on Why Measuring Real World Mobility Matters. To see the full paper with a comprehensive set of references, please download the paper here. Mobility loss is common, and the implications are profound… Read More